These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16920558)

  • 1. Incidence of delirium and associated mortality in hematopoietic stem cell transplantation patients.
    Beglinger LJ; Duff K; Van Der Heiden S; Parrott K; Langbehn D; Gingrich R
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):928-35. PubMed ID: 16920558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Kataoka K; Nannya Y; Hangaishi A; Imai Y; Chiba S; Takahashi T; Kurokawa M
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):195-204. PubMed ID: 19167679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants.
    Martinez MT; Bucher Ch; Stussi G; Heim D; Buser A; Tsakiris DA; Tichelli A; Gratwohl A; Passweg JR
    Bone Marrow Transplant; 2005 Dec; 36(11):993-1000. PubMed ID: 16184183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation.
    Forslöw U; Mattsson J; Ringden O; Klominek J; Remberger M
    Scand J Infect Dis; 2006; 38(11-12):970-6. PubMed ID: 17148063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation of delirium in patients undergoing hematopoietic stem cell transplantation.
    Fann JR; Alfano CM; Burington BE; Roth-Roemer S; Katon WJ; Syrjala KL
    Cancer; 2005 Feb; 103(4):810-20. PubMed ID: 15643598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning.
    Ganti AK; Lee SJ; Vose JM; Devetten MP; Bociek RG; Armitage JO; Bierman PJ; Maness LJ; Reed EC; Loberiza FR
    J Clin Oncol; 2007 Dec; 25(35):5643-8. PubMed ID: 18065735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delirium in patients undergoing hematopoietic stem cell transplantation.
    Fann JR; Roth-Roemer S; Burington BE; Katon WJ; Syrjala KL
    Cancer; 2002 Nov; 95(9):1971-81. PubMed ID: 12404292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients.
    Sanz J; Arriaga F; Montesinos P; Ortí G; Lorenzo I; Cantero S; Puig N; Moscardó F; de la Rubia J; Sanz G; Sanz MA
    Bone Marrow Transplant; 2007 May; 39(9):555-61. PubMed ID: 17351645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Michallet M; Le QH; Mohty M; Prébet T; Nicolini F; Boiron JM; Esperou H; Attal M; Milpied N; Lioure B; Bordigoni P; Yakoub-Agha I; Bourhis JH; Rio B; Deconinck E; Renaud M; Chir Z; Blaise D
    Exp Hematol; 2008 May; 36(5):535-44. PubMed ID: 18346838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation.
    Kersting S; Hené RJ; Koomans HA; Verdonck LF
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1169-75. PubMed ID: 17889353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
    Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
    Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation.
    Kontoyiannis DP; Chamilos G; Lewis RE; Giralt S; Cortes J; Raad II; Manning JT; Han X
    Cancer; 2007 Sep; 110(6):1303-6. PubMed ID: 17614303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
    Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
    J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation.
    Prieto JM; Atala J; Blanch J; Carreras E; Rovira M; Cirera E; Espinal A; Gasto C
    J Clin Oncol; 2005 Sep; 23(25):6063-71. PubMed ID: 16087949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation.
    Zhu KE; Hu JY; Zhang T; Chen J; Zhong J; Lu YH
    Eur J Haematol; 2008 Dec; 81(6):461-6. PubMed ID: 18774951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.